739 related articles for article (PubMed ID: 30626440)
1. Targeting the glucagon receptor improves cardiac function and enhances insulin sensitivity following a myocardial infarction.
Karwi QG; Zhang L; Wagg CS; Wang W; Ghandi M; Thai D; Yan H; Ussher JR; Oudit GY; Lopaschuk GD
Cardiovasc Diabetol; 2019 Jan; 18(1):1. PubMed ID: 30626440
[TBL] [Abstract][Full Text] [Related]
2. Adiponectin determines farnesoid X receptor agonism-mediated cardioprotection against post-infarction remodelling and dysfunction.
Xia Y; Zhang F; Zhao S; Li Y; Chen X; Gao E; Xu X; Xiong Z; Zhang X; Zhang J; Zhao H; Wang W; Wang H; Guo Y; Liu Y; Li C; Wang S; Zhang L; Yan W; Tao L
Cardiovasc Res; 2018 Aug; 114(10):1335-1349. PubMed ID: 29668847
[TBL] [Abstract][Full Text] [Related]
3. Myocardial infarction in rats causes partial impairment in insulin response associated with reduced fatty acid oxidation and mitochondrial gene expression.
Amorim PA; Nguyen TD; Shingu Y; Schwarzer M; Mohr FW; Schrepper A; Doenst T
J Thorac Cardiovasc Surg; 2010 Nov; 140(5):1160-7. PubMed ID: 20850803
[TBL] [Abstract][Full Text] [Related]
4. Exendin-4 induces myocardial protection through MKK3 and Akt-1 in infarcted hearts.
Du J; Zhang L; Wang Z; Yano N; Zhao YT; Wei L; Dubielecka-Szczerba P; Liu PY; Zhuang S; Qin G; Zhao TC
Am J Physiol Cell Physiol; 2016 Feb; 310(4):C270-83. PubMed ID: 26739490
[TBL] [Abstract][Full Text] [Related]
5. Glucagon-like peptide-1 and the exenatide analogue AC3174 improve cardiac function, cardiac remodeling, and survival in rats with chronic heart failure.
Liu Q; Anderson C; Broyde A; Polizzi C; Fernandez R; Baron A; Parkes DG
Cardiovasc Diabetol; 2010 Nov; 9():76. PubMed ID: 21080957
[TBL] [Abstract][Full Text] [Related]
6. Impaired branched chain amino acid oxidation contributes to cardiac insulin resistance in heart failure.
Uddin GM; Zhang L; Shah S; Fukushima A; Wagg CS; Gopal K; Al Batran R; Pherwani S; Ho KL; Boisvenue J; Karwi QG; Altamimi T; Wishart DS; Dyck JRB; Ussher JR; Oudit GY; Lopaschuk GD
Cardiovasc Diabetol; 2019 Jul; 18(1):86. PubMed ID: 31277657
[TBL] [Abstract][Full Text] [Related]
7. Metformin improves cardiac function in a nondiabetic rat model of post-MI heart failure.
Yin M; van der Horst IC; van Melle JP; Qian C; van Gilst WH; Silljé HH; de Boer RA
Am J Physiol Heart Circ Physiol; 2011 Aug; 301(2):H459-68. PubMed ID: 21572014
[TBL] [Abstract][Full Text] [Related]
8. Defective branched chain amino acid catabolism contributes to cardiac dysfunction and remodeling following myocardial infarction.
Wang W; Zhang F; Xia Y; Zhao S; Yan W; Wang H; Lee Y; Li C; Zhang L; Lian K; Gao E; Cheng H; Tao L
Am J Physiol Heart Circ Physiol; 2016 Nov; 311(5):H1160-H1169. PubMed ID: 27542406
[TBL] [Abstract][Full Text] [Related]
9. P2Y12 antagonists and cardiac repair post-myocardial infarction: global and regional heart function analysis and molecular assessments in pigs.
Vilahur G; Gutiérrez M; Casani L; Lambert C; Mendieta G; Ben-Aicha S; Capdevila A; Pons-Lladó G; Carreras F; Carlsson L; Hidalgo A; Badimon L
Cardiovasc Res; 2018 Dec; 114(14):1860-1870. PubMed ID: 30124783
[TBL] [Abstract][Full Text] [Related]
10. Sodium-glucose co-transporter 2 inhibition with empagliflozin improves cardiac function in non-diabetic rats with left ventricular dysfunction after myocardial infarction.
Yurista SR; Silljé HHW; Oberdorf-Maass SU; Schouten EM; Pavez Giani MG; Hillebrands JL; van Goor H; van Veldhuisen DJ; de Boer RA; Westenbrink BD
Eur J Heart Fail; 2019 Jul; 21(7):862-873. PubMed ID: 31033127
[TBL] [Abstract][Full Text] [Related]
11. Chronic urocortin 2 administration improves cardiac function and ameliorates cardiac remodeling after experimental myocardial infarction.
Ellmers LJ; Scott NJ; Cameron VA; Richards AM; Rademaker MT
J Cardiovasc Pharmacol; 2015 Mar; 65(3):269-75. PubMed ID: 25658462
[TBL] [Abstract][Full Text] [Related]
12. Adropin regulates cardiac energy metabolism and improves cardiac function and efficiency.
Altamimi TR; Gao S; Karwi QG; Fukushima A; Rawat S; Wagg CS; Zhang L; Lopaschuk GD
Metabolism; 2019 Sep; 98():37-48. PubMed ID: 31202835
[TBL] [Abstract][Full Text] [Related]
13. Stimulation of glucagon-like peptide-1 receptor through exendin-4 preserves myocardial performance and prevents cardiac remodeling in infarcted myocardium.
DeNicola M; Du J; Wang Z; Yano N; Zhang L; Wang Y; Qin G; Zhuang S; Zhao TC
Am J Physiol Endocrinol Metab; 2014 Oct; 307(8):E630-43. PubMed ID: 25117407
[TBL] [Abstract][Full Text] [Related]
14. Cardiac insulin-resistance and decreased mitochondrial energy production precede the development of systolic heart failure after pressure-overload hypertrophy.
Zhang L; Jaswal JS; Ussher JR; Sankaralingam S; Wagg C; Zaugg M; Lopaschuk GD
Circ Heart Fail; 2013 Sep; 6(5):1039-48. PubMed ID: 23861485
[TBL] [Abstract][Full Text] [Related]
15. Qiliqiangxin improves cardiac function and attenuates cardiac remodeling in rats with experimental myocardial infarction.
Wang J; Zhou J; Ding X; Zhu L; Jiang K; Fu M; Wang S; Hu K; Ge J
Int J Clin Exp Pathol; 2015; 8(6):6596-606. PubMed ID: 26261541
[TBL] [Abstract][Full Text] [Related]
16. Mesenchymal stem cell transplantation for the infarcted heart: therapeutic potential for insulin resistance beyond the heart.
Hughey CC; Ma L; James FD; Bracy DP; Wang Z; Wasserman DH; Rottman JN; Hittel DS; Shearer J
Cardiovasc Diabetol; 2013 Sep; 12():128. PubMed ID: 24007410
[TBL] [Abstract][Full Text] [Related]
17. Increased ketone body oxidation provides additional energy for the failing heart without improving cardiac efficiency.
Ho KL; Zhang L; Wagg C; Al Batran R; Gopal K; Levasseur J; Leone T; Dyck JRB; Ussher JR; Muoio DM; Kelly DP; Lopaschuk GD
Cardiovasc Res; 2019 Sep; 115(11):1606-1616. PubMed ID: 30778524
[TBL] [Abstract][Full Text] [Related]
18. Total flavonoids from Anchusa italica Retz. Improve cardiac function and attenuate cardiac remodeling post myocardial infarction in mice.
Wang S; Zhao Y; Song J; Wang R; Gao L; Zhang L; Fang L; Lu Y; Du G
J Ethnopharmacol; 2020 Jul; 257():112887. PubMed ID: 32315737
[TBL] [Abstract][Full Text] [Related]
19. Load-independent effects of empagliflozin contribute to improved cardiac function in experimental heart failure with reduced ejection fraction.
Connelly KA; Zhang Y; Desjardins JF; Nghiem L; Visram A; Batchu SN; Yerra VG; Kabir G; Thai K; Advani A; Gilbert RE
Cardiovasc Diabetol; 2020 Feb; 19(1):13. PubMed ID: 32035482
[TBL] [Abstract][Full Text] [Related]
20. Berberine attenuates adverse left ventricular remodeling and cardiac dysfunction after acute myocardial infarction in rats: role of autophagy.
Zhang YJ; Yang SH; Li MH; Iqbal J; Bourantas CV; Mi QY; Yu YH; Li JJ; Zhao SL; Tian NL; Chen SL
Clin Exp Pharmacol Physiol; 2014 Dec; 41(12):995-1002. PubMed ID: 25224725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
